Arginine-vasopressin stimulates CRH and ACTH release by rat adrenal medulla, acting via the V1 receptor subtype and a protein kinase C-dependent pathway

Peptides

Volumn 18, Issue 2, 1997, Pages 191-195

  Mazzocchi, Giuseppina ^a   Malendowicz, Ludwik K ^a   Rebuffat, Pierra ^a   Tortorella, Cinzia ^a   Nussdorfer, Gastone G ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

ACTH; Adrenal medulla; Arginine vasopressin; CRH; Rat

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ARGIPRESSIN; ARGIPRESSIN RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HORMONE RECEPTOR; PROTEIN KINASE C;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ADRENAL MEDULLA; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CORTICOTROPIN-RELEASING HORMONE; ENZYME INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDOLES; KINETICS; MALE; NAPHTHALENES; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN;

ANIMALIA;

EID: 0030977528     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00294-X     Document Type: Article

References (50)

1. Aguilera G., Millan M. A., Hauger R. L., Catt K. J. Corticotropin-releasing factor receptors: Distribution and regulation in brain, pituitary and peripheral tissues. Ann. NY Acad. Sci. 512:1987;48-66.
2. Andreis P. G., Neri G., Mazzocchi G., Musajo F. G., Nussdorfer G. G. Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: The involvement of the zona medullaris. Endocrinology. 131:1992;69-72.
3. Ang V. T. Y., Jenkins J. S. Neurohypophysial hormones in the adrenal medulla. J. Clin. Endocrinol. Metab. 58:1984;688-691.
4. Antoni F. A. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 7:1986;351-378.
5. Bagdy G., Calogero A. E., Szemeredi K., Chrousos G. P., Gold P. W. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH. Regul. Pept. 31:1990;83-92.
6. Balla T., Enyedi P., Spät A., Antoni F. A. Pressor-type vasopressin receptors in the adrenal cortex: Properties of binding effects on phosphoinositide metabolism and aldosterone secretion. Endocrinology. 117:1985;421-423.
7. Baylis P. H. Vasopressin and its neurophysin. De Groot L. J. Endocrinology. 1:1989;213-219 W. B. Saunders Co, Philadephia.
8. Bernardini R., Chiarenza A., Kamilaris T. C., Renaud N., Lempreur L., Demitrak M., Gold P. W., Chrousos G. P. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology. 60:1994;503-508.
9. Buckingham J. C., Smith T., Loxley H. D. The control of ACTH secretion. James V. H. T. The adrenal gland. 1992;131-158 Raven Press, New York.
10. Dave J. R., Eiden L. E., Eskay R. L. Corticotropin-releasing factor binding to peripheral tissues and activation of the adenylate cyclase-adenosine 3′,5′-monophosphate system. Endocrinology. 116:1985;2152-2159.
11. De Goeij D. C. E., Jezova D., Tilders F. J. H. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res. 577:1992;165-168.
12. Dunn F. L., Brennan T. J., Nelson A. E., Robertson G. L. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J. Clin. Invest. 52:1973;3212-3219.
13. Enyedi P., Balla T., Antoni F. A., Spät A. Effect of angiotensin II and arginine vasopressin on aldosterone production and phosphoinositide turnover in rat adrenal glomerulosa cells: A comparative study. J. Mol. Endocrinol. 1:1988;117-124.
14. 1 vasopressin receptor and phospholipase C in rat glomerulosa cells. Effects on aldosterone secretion. Endocrinology. 129:1991;623-634.
15. 1b vasopressin receptor in rat adrenal medulla. Endocrinology. 137:1996;3906-3914.
16. Guillon G., Balestre M. N., Chouinard L., Gallo-Payet N. Involvement of distinct G-proteins in the action of vasopressin on rat glomerulosa cells. Endocrinology. 126:1990;1699-1708.
17. Guillon G., Trueba M., Joubert D., Grazzini E., Chouinard L., Côté M., Payet M. D., Manzoni O., Barberis C., Robert M., Gallo-Payet N. Vasopressin stimulates steroid secretion in human adrenal glands: Comparison with angiotensin-II effect. Endocrinology. 136:1995;1285-1295.
18. Harbuz M. S., Lightman S. L. Stress and the hypothalamo-pituitary-adrenal axis: Acute, chronic and immunological activation. Endocrinology. 134:1992;327-339.
19. Hashimoto K., Murakami K., Hattori T., Niimi M., Fijimo K., Ota Z. Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla. Peptides. 5:1984;707-712.
20. Hauger R. L., Aguilera G. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: Interaction with vasopressin. Endocrinology. 133:1993;1708-1714.
21. Hawthorn J., Nussey S. S., Henderson J. R., Jenkins J. S. Immunohistochemical localization of oxytocin and vasopressin in the adrenal glands of rat, cow, hamster and guinea pig. Cell Tissue Res. 250:1987;1-6.
22. Hinson J. P., Vinson G. P., Porter I. D., Whitehouse B. J. Oxytocin and arginine vasopressin stimulate steroid secretion by the isolated perfused rat adrenal gland. Neuropeptides. 10:1987;1-7.
23. Jard S., Gaillard R. C., Guillon G., Marie J., Schönenberg P., Müller A. F., Manning M., Sawyer W. H. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol. Pharmacol. 30:1986;171-177.
24. Karalis K., Sano H., Redwine J., Listwak S., Wilder R. L., Chrousos G. P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:1991;421-423.
25. Kavelaars A., Berkenbosch F., Croiset G., Ballieux R. E., Heijnen C. J. Induction of β -endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology. 126:1990;759-764.
26. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-553.
27. Lesniewska B., Nowak M., Miskowiak B., Nussdorfer G. G., Malendowicz L. K. Effects of arginine-vasopressin on the pituitary-adrenocortical axis of intact and dexamethasone-suppressed rats. Exp. Pathol. 43:1991;181-188.
28. Liu J., Heikkilä P., Voutilainen R., Koronen S. L., Kahri A. I. Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor. Eur. J. Endocrinol. 131:1994;221-228.
29. 1-receptor) responses to vasopressin. J. Med. Chem. 33:1990;3079-3085.
30. Mazzocchi G., Malendowicz L. K., Meneghelli V., Gottardo G., Nussdorfer G. G. In vitro and in vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex. Histol. Histopathol. 10:1995;359-370.
31. Mazzocchi G., Markowska A., Malendowicz L. K., Musajo F. G., Meneghelli V., Nussdorfer G. G. Evidence that endogenous arginine-vasopressin (AVP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa. J. Steroid Biochem. Mol. Biol. 45:1993;251-256.
32. Mazzocchi G., Musajo F. G., Malendowicz L. K., Andreis P. G., Nussdorfer G. G. Interleukin-1 stimulates corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH) release by rat adrenal gland in vitro. Mol. Cell. Neurosci. 4:1993;267-270.
33. Nicholson H. D., Swann R. W., Burford G. D., Wathes D. C., Porter D. G., Pickering B. T. Identification of oxytocin and vasopressin in the testis and in adrenal tissue. Regul. Pept. 8:1984;141-146.
34. Nussdorfer G. G. Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol. Rev. 48:1996;495-530.
35. Ravid R., Oosterbaan H. P., Hausen B. L., Swaab D. F. Localization of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal. Histochemistry. 84:1986;401-407.
36. Rivier J., Rivier C., Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: Effect on ACTH secretion in the rat. Science. 224:1984;889-890.
37. Sawchenko P. E., Swanson L. W., Vale W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc. Natl. Acad. Sci. USA. 81:1984;1883-1887.
38. Smith E. M., Morril A. C., Meyer W. J., Blalock J. E. Corticotropin-releasing factor induction of leucocyte-derived immunoreactive ACTH and endorphin. Nature. 321:1986;881-882.
39. Szemeredi K., Bagdy G., Stull R., Calogero A. E., Kopin I. J., Goldstein D. S. Sympatho-adrenomedullary inhibition by chronic glucocorticoid treatment in conscious rats. Endocrinology. 123:1988;2585-2590.
40. Torpy D. J., Grice J. E., Hocking G. I., Walters M. M., Crosbie G. V., Jackson R. V. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: Evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. J. Clin. Endocrinol. Metab. 79:1994;140-144.
41. Tramu G., Croix C., Pillez A. Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Neuroendocrinology. 37:1983;467-469.
42. Udelsman R., Harwood J. P., Millan M. A., Chrousos G. P., Goldstein D. S., Zimlichman R., Catt K. J., Aguilera G. Functional corticotropin-releasing factor receptors in the primate peripheral sympathetic nervous system. Nature. 319:1986;147-150.
43. Usui T., Nakai Y., Tsukada T., Jingami H., Takahashi H., Fukada J., Imura H. Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol. Endocrinol. 2:1988;871-875.
44. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β -endorphin. Science. 233:1981;1394-1397.
45. Vale W., Vaughan J., Yamamoto G., Bruhn T., Douglas C., Dalton D., Rivier C., Rivier J. Assay of corticotropin-releasing factor. Methods Enzymol. 103:1983;565-577.
46. Watanabe T., Oki Y., Orth D. N. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system. Endocrinology. 125:1989;1921-1931.
47. Watanabe T., Orth D.N. Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: Effects of ovine corticotropin-releasing factor and arginine vasopressin. Endocrinology. 121:1987;1133-1145.
48. Whitnall M. H. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. Neuroendocrinology. 50:1989;702-707.
49. Whitnall M. H., Smith D., Gainer H. Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats. Neuroendocrinology. 45:1987;420-424.
50. Wilkinson S. E., Hallam T. J. Protein kinase C: Is its pivotal role in cellular activation over-stated. Trends Pharmacol. Sci. 15:1994;53-57.